Un panthéon métis en Inde portugaise

by Martine Amiot-Guigaz
Published 2007-01-01

Règlement de compte à Mexico

by Martine Amiot-Guigaz
Published 2006-01-01

Goa, une autre Inde

by Martine Amiot-Guigaz
Published 2007-01-01

Règlement de compte à Mexico

by Martine Amiot-Guigaz
Published 2006-01-01

Goa, une autre Inde

by Martine Amiot-Guigaz
Published 2007-01-01

Un panthéon métis en Inde portugaise

by Martine Amiot-Guigaz
Published 2007-01-01

Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells

by Benoit Tessoulin, Benoit Tessoulin, Benoit Tessoulin, Benoit Tessoulin, Geraldine Descamps, Geraldine Descamps, Geraldine Descamps, Christelle Dousset, Christelle Dousset, Christelle Dousset, Martine Amiot, Martine Amiot, Martine Amiot, Catherine Pellat-Deceunynck, Catherine Pellat-Deceunynck, Catherine Pellat-Deceunynck
Published 2019-03-01

BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker

by Benoît Tessoulin, Benoît Tessoulin, Benoît Tessoulin, Antonin Papin, Antonin Papin, Antonin Papin, Patricia Gomez-Bougie, Patricia Gomez-Bougie, Patricia Gomez-Bougie, Celine Bellanger, Celine Bellanger, Celine Bellanger, Martine Amiot, Martine Amiot, Martine Amiot, Catherine Pellat-Deceunynck, Catherine Pellat-Deceunynck, Catherine Pellat-Deceunynck, David Chiron, David Chiron, David Chiron
Published 2019-01-01

Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)

by Cyrille Touzeau, Steven Le Gouill, Béatrice Mahé, Jean Samuel Boudreault, Thomas Gastinne, Nicolas Blin, Hélène Caillon, Christelle Dousset, Martine Amiot, Philippe Moreau
Published 2017-03-01

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

by Jérôme Moreaux, Bernard Klein, Régis Bataille, Géraldine Descamps, Sophie Maïga, Dirk Hose, Hartmut Goldschmidt, Anna Jauch, Thierry Rème, Michel Jourdan, Martine Amiot, Catherine Pellat-Deceunynck
Published 2011-04-01

BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival

by Ophélie Champion, Alana Soler, Sophie Maïga, Sophie Maïga, Céline Bellanger, Catherine Pellat-Deceunynck, Catherine Pellat-Deceunynck, Alexis Talbot, Cyrille Touzeau, Cyrille Touzeau, Martine Amiot, Patricia Gomez-Bougie
Published 2023-07-01

Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways

by Benoît Tessoulin, Agnès Moreau-Aubry, Géraldine Descamps, Patricia Gomez-Bougie, Sophie Maïga, Alban Gaignard, David Chiron, Emmanuelle Ménoret, Steven Le Gouill, Philippe Moreau, Martine Amiot, Catherine Pellat-Deceunynck
Published 2018-12-01

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells

by Pierre-Samuel Gillardin, Géraldine Descamps, Sophie Maiga, Benoit Tessoulin, Hanane Djamai, Benedetta Lucani, David Chiron, Philippe Moreau, Steven Le Gouill, Martine Amiot, Catherine Pellat-Deceunynck, Agnès Moreau-Aubry
Published 2017-12-01

The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma

by Lina Benaniba, Benoit Tessoulin, Sabrina Trudel, Catherine Pellat-Deceunynck, Martine Amiot, Stéphane Minvielle, Pierre Antoine Gourraud, Sophie de Visme, Hervé Maisonneuve, Anne Lok, Steven Le Gouill, Philippe Moreau, Cyrille Touzeau
Published 2019-08-01

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells

by Paola Storti, Denise Toscani, Irma Airoldi, Valentina Marchica, Sophie Maiga, Marina Bolzoni, Elena Fiorini, Nicoletta Campanini, Eugenia Martella, Cristina Mancini, Daniela Guasco, Valentina Ferri, Gaetano Donofrio, Franco Aversa, Martine Amiot, Nicola Giuliani
Published 2016-03-01